Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia
To access this article, please choose from the options below
PII: S0145-2126(05)00255-9
doi:10.1016/j.leukres.2005.06.013
© 2005 Elsevier Ltd. All rights reserved.
